A mutant B7-1/Ig fusion protein that selectively binds to CTLA-4 ameliorates anti-tumor DNA vaccination and counters regulatory T cell activity
- 31 August 2005
- Vol. 23 (37) , 4553-4564
- https://doi.org/10.1016/j.vaccine.2005.05.002
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- DNA vaccination against tumorsThe Journal of Gene Medicine, 2004
- Emerging mechanisms of immune regulation: the extended B7 family and regulatory T cellsArthritis Research & Therapy, 2004
- Control of immune homeostasis by naturally arising regulatory CD4+ T cellsCurrent Opinion in Immunology, 2003
- Plasmids encoding membrane-bound IL-4 or IL-12 strongly costimulate DNA vaccination against carcinoembryonic antigen (CEA)Vaccine, 2003
- DNA vaccines for non-infectious diseases: new treatments for tumour and allergyExpert Opinion on Biological Therapy, 2003
- DNA vaccinationEmerging Drugs, 2003
- The Potential of DNA Vaccination against Tumor-Associated Antigens for Antitumor TherapyExperimental Biology and Medicine, 2002
- IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout miceGene Therapy, 2000
- DNA Vaccines: Immunology, Application, and OptimizationAnnual Review of Immunology, 2000
- Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transferGene Therapy, 2000